| Application no. and date | 15720982.6 (espacenet) (Federated) (European Patent Register), 20150505 | | Patent/reg. no. and date | DK/EP 3139948, 20200304 | | Publication date | 20170315 | | Priority no. and date | US 201461989841 P, 20140507, EP 14169596, 20140523, EP 14189732, 20141021 | | EP pub. no. and date |
EP 3139948 20170315 | | Effective date | | | Applicant/owner | Novo Nordisk A/S, Novo Allé 1, 2880 Bagsværd, DK | | Applicant ref. no. | P73015DK01 | | Inventor | COPPIETERS, Ken, Novo Nordisk A/S
Novo Allé, 2880 Bagsværd, DK,
VON HERRATH, Matthias, Novo Nordisk INC.
530 Fairview Avenue North
Seattle, Washington 98109, US,
BOURSALIAN, Tamar, Novo NordiskInc.
530 Fairview Avenue North
Seattle, Washington 98109, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61P 3/10 (2006.01) , C07K 16/24 (2006.01) | | Title | BEHANDLING AF TYPE 1 DIABETES UNDER ANVENDELSE AF GLP-1 OG ANTI-IL-21 | | Int. application no. | EP2015059811 | | Int. publication no. | WO2015169789 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
